Dashboard
Manage Tickers

ENSCEnsysce Biosciences, Inc.

Nasdaq ensysce.com


$ 0.38 $ -0.01 (-3.45 %)    

Friday, 30-Aug-2024 15:10:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 0.395001
$ 0.38 x 100
-- x --
-- - --
$ 0.36 - $ 2.06
920,852
na
3.35M
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-14-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 06-08-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 03-11-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 03-09-2018 12-31-2017 10-K
28 01-09-2018 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crude-oil-moves-higher-dollar-general-earnings-miss-estimates
Crude Oil Moves Higher; Dollar General Ear...
08/29/2024 18:30:33

nasdaq-surges-over-1-best-buy-posts-upbeat-earnings
Nasdaq Surges Over 1%; Best Buy Posts Upbe...
08/29/2024 16:19:56

ensysce-biosciences-ensc-stock-is-down-30-today-whats-going-on
Ensysce Biosciences (ENSC) Stock Is Down 3...
08/29/2024 15:10:22

Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registere...

dow-jumps-over-100-points-nvidia-earnings-top-views
Dow Jumps Over 100 Points; Nvidia Earnings...
08/29/2024 14:00:51

ensysce-biosciences-announces-5m-registered-direct-offering-and-concurrent-private-placement-issuing-355m-shares-of-common-stock-and-warrants-at-047-per-share-proceeds-to-support-development-of-abuse-deterrent-opioid-pf614-mpar-and-other-programs
Ensysce Biosciences Announces $5M Register...
08/29/2024 12:05:48

why-nordstrom-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Nordstrom Shares Are Trading Higher By...
08/28/2024 09:13:33

sp-500-edges-higher-american-woodmark-shares-slide
S&P 500 Edges Higher; American Woodmark Sh...
08/27/2024 18:41:04

crude-oil-dips-addex-therapeutics-shares-spike-higher
Crude Oil Dips; Addex Therapeutics Shares ...
08/27/2024 16:03:57

us-stocks-mixed-scansource-reports-weak-q4-results
US Stocks Mixed; ScanSource Reports Weak Q...
08/27/2024 13:39:49

ensysce-biosciences-receives-14m-multi-year-grant-from-nih-for-continued-development-of-pf614-mpar-abuse-deterrent-opioid-with-overdose-protection
Ensysce Biosciences Receives $14M Multi-Ye...
08/27/2024 12:09:26

watching-ensysce-biosciences-zacks-small-cap-research-gives-stock-1725-price-valuation
Watching Ensysce Biosciences; Zacks Small-...
08/15/2024 16:11:55

https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_08152024_ENSC_Sorensen.pdf

ensysce-biosciences-q2-eps-022-beats-039-estimate-sales-18180k-miss-30000k-estimate
Ensysce Biosciences Q2 EPS $(0.22) Beats $...
08/14/2024 20:49:42

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $...

ensysce-biosciences-to-host-symposium-on-safer-analgesics-at-iasp-2024-world-congress-ceo-dr-lynn-kirkpatrick-to-introduce-event-featuring-pain-experts-dr-lars-arendt-nielsen-and-dr-william-schmidt
Ensysce Biosciences To Host Symposium On S...
07/23/2024 12:10:39

why-sarepta-therapeutics-shares-are-trading-higher-by-around-35-here-are-20-stocks-moving-premarket
Why Sarepta Therapeutics Shares Are Tradin...
06/21/2024 12:22:36

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 20:31:11

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

ensysce-biosciences-regains-nasdaq-compliance
Ensysce Biosciences Regains Nasdaq Compliance
05/28/2024 12:06:42

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company d...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 12:06:48

ensysce-biosciences-renews-collaboration-with-quotient-sciences-to-undertake-the-study-pf614-mpar-102-to-examine-and-evaluate-the-full-commercial-dose-range-of-the-pf614-mpar-drug-product
Ensysce Biosciences Renews Collaboration W...
05/20/2024 12:07:52

New Study to Confirm Overdose Protection Across Full Dosage Range of Breakthrough Therapy Opioid PF614-MPARSAN DIEGO, CA / ACCE...

ensysce-biosciences-q1-2024-gaap-eps-055-beats-090-estimate-sales-305722k-miss-400000k-estimate
Ensysce Biosciences Q1 2024 GAAP EPS $(0.5...
05/13/2024 12:27:23

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION